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Abstract
Background: Mosquito-proofing homes was one of the principal methods of environmental
management in the early 1900s. House screening provides protection against malaria by reducing
exposure to malaria parasites and has the added benefit of protecting everyone sleeping in the
house, avoiding issues of inequity within the household. The aim of this study is to determine
whether house screening protects people against malaria in Africa. It is hoped that this study will
mark the beginning of a series of trials assessing a range of environmental interventions for malaria
control in Africa.
Design: A 3-armed randomised-controlled trial will be conducted in and around Farafenni town
in The Gambia, West Africa, to assess whether screening windows, doors and closing eaves or
installing netting ceilings in local houses can substantially reduce malaria transmission and anaemia
compared to homes with no screening. Eligible houses will be sorted and stratified by location and
the number of children in each house, then randomly allocated to the interventions in blocks of 5
houses (2 with full screening, 2 with screened ceilings and 1 control house without screening). Risk
of malaria transmission will be assessed in each house by routine collections of mosquitoes using
light traps and an anaemia prevalence study in children at the end of the main transmission period.
Discussion: Practical issues concerning intervention implementation, as well as the potential
benefits and risks of the study, are discussed.
Trial Registration: ISRCTN51184253 – Screening-homes to prevent malaria
Background
Malaria remains one of the greatest childhood killers in
the world[1] and is a substantial obstacle to social and
economic development[2]. We know from historical
accounts that in the early 1900s malaria was controlled
using environmental management (EM) for vector con-
trol in many parts of the tropics [3-5]. EM was effective
and sustainable in controlling and eradicating malaria,
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but was forgotten during the DDT campaigns of the 1950s
and 1960s. Today most control tools rely exclusively on
chemicals (anti-malarial drugs and insecticides), not on
environmental modifications, nor on strengthened social
systems to perform effective environmental manipula-
tion. Whilst drugs and insecticides are extremely effective
weapons, their initial promise has been compromised by
the development of resistance [6-10] and growing con-
cerns about long-term environmental impacts[11]. It is
therefore of considerable strategic importance to reduce
our dependency on antimalarials and insecticides by
developing effective and sustainable methods of control.
EM could help achieve this and provides new opportuni-
ties for the control of malaria that could be incorporated
into integrated disease control programmes, providing a
more effective, environmentally friendly and sustainable
approach to malaria control.
Mosquito-proofing homes was one of the principal meth-
ods of EM in the early 1900s (Fig 1) and it should be effec-
tive against malaria in Africa since the majority of people
receive infective bites at night indoors.
The literature review of Lindsay et al. provides compelling
evidence that house screening has been associated with
protection against malaria transmission, infection and
morbidity[12]. Furthermore, a pilot study conducted in
The Gambia using experimental huts demonstrated that
netting ceilings alone can reduce exposure to malaria vec-
tors by 80%[13]. In this situation, most mosquitoes
entered the huts through the open eaves and were effec-
tively trapped in the roof space. Further studies in actual
village houses are needed to confirm these findings and to
assess the acceptability of the intervention to house-hold-
ers.
Methods
Study area, house- and participant eligibility
The study area is situated approximately 170 km from the
mouth of the Gambia River and covers 70 km2 of the
North Bank Division in The Gambia, an area of open
Sudan savanna vegetation. The climate consists of a single
rainy season from June to October followed by a long dry
season. Specifically, the study area comprises 500 houses;
46 in 11 residential blocks in Farafenni town (UTM coor-
dinates: 1500200N, 435500E) and 454 in 25 villages
located within 15 km of the town. Farafenni itself is a mar-
ket town with a population of over 20,000 inhabitants,
situated less than 5 km from the river and 2 km south of
the border with Senegal. Houses in both the town and sur-
rounding villages are usually arranged in familial com-
pounds demarcated by a fence or wall, though there are
some in which the houses are rented by unrelated family
groups. Compounds in Farafenni contain typically 1–4
houses and in the villages 4–6 houses, but sometimes as
many as 20. Houses must meet 6 eligibility criteria in
order to be selected: (1) they must be single storey build-
ings, (2) have open eaves, (3) with no more than four
rooms, (4) have no existing ceilings, (5) have no screening
and (6) at least one child, aged 6 months to 10 years, must
sleep in the house at night. Most of the houses to choose
from are part of the Farafenni demographic surveillance
system (FDSS) that incorporates 46 residential blocks in
the town and 23 surrounding villages, also defined as
individual blocks within the FDSS.
The study area population comprises 7852 people domi-
nated by three ethnic groups; Mandinka (28%), Wollof
(38%) and Fula (27%). There are roughly equal numbers
of men (53%) and women. The study aims to recruit 1250
children aged 6 months to 10 years, as this is the age
group most affected by the clinical manifestations of
malaria. No distinctions are made regarding gender or
ethnic group. Moreover, as the target population will in
reality be all children occupying study houses, and in
order for the results from this study to be broadly applica-
ble, no distinctions are made in terms of medical condi-
tion or physical health.
Sensitization
Village meetings will be held to explain to the villagers the
purpose of the study and the benefit they will receive from
participation in the trial. Each meeting will end with an
opportunity for asking and answering questions.
Informed verbal and written consent is sought from the
parents or guardians of children who fulfil the entry crite-
ria for the study.
Design
In each of 2 intervention years we will erect; full screening
on the door(s) and windows and close the eaves with a
A screened entrance to a thatched house in rural Italy in 1900, in an experim nt where screening reduced m laria by 96% [20]Figure 1
A screened entrance to a thatched house in rural Italy in 
1900, in an experiment where screening reduced malaria by 
96% [20]. This illustrates that even extremely poor housing 
can be protected from mosquitoes.
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mixture of sand, rubble and cement (as is normal local
practice) in 100 houses and install screened ceilings in a
further 100 houses. 50 houses without any screening will
serve as a control group. Thus we will enroll a total of 500
houses over the 2 year study. Screening will be installed
prior to the rainy season of each year (January to May). All
rooms in the house will be screened, not just the target
bedroom(s).
Exposure to mosquitoes will be measured by routine sur-
veillance with light traps, fitted near a participant sleeping
under an untreated bednet. All children sleeping in eligi-
ble houses will sleep under an untreated bednet and their
exposure to malaria parasites estimated by (1) haemo-
globin density (Hb), (2) percentage of children with anae-
mia (<8 g/dL), (3) percentage of children with severe
anaemia (<5 g/dL), (4) parasite prevalence and (5) high
parasite prevalence (> = 5000 parasites/μl), as determined
by a cross-sectional survey at the end of the transmission
season. At the end of the trial the participants in the con-
trol group will be able to choose to have their houses
screened, and participants in either of the screening
groups will be able to choose to keep that screening, have
it removed, or have it changed to the other type of screen-
ing. In addition, insecticide-treated nets (ITN) will be pro-
vided to all study subjects at the end of the trial.
Randomisation
Eligible houses will be sorted and stratified by (1) rural
(village) or urban (Farafenni) location, (2) block and (3)
the number of children in each house. The randomization
list will be generated by PM in blocks of 5 (2 full screening
interventions: 2 ceiling screening interventions 1: control)
using Stata 7(StataCorp., College Station, TX, USA). The
randomization should give a reasonable balance between
groups in the roof type, ITN use, the number of malaria
vectors (Anopheles gambiae s.l.) caught from the houses in
a pilot study [14], and the number of doors and windows.
Ideally we would have preferred to hold a raffle to allocate
the intervention and control treatments to houses, so that
the participants could witness the evenhandedness of the
randomization. However, because the exact number of
houses within each randomization block is known, it
would not be possible to conceal the identity of the last
allocation to be drawn in each block. If the last ticket were
known to be a control ticket, there is the possibility of it
not being drawn and the participant withdrawing from
the study, resulting in a potential source of bias. Partici-
pants will therefore be enrolled into their respective
groups by the project field staff.
Interventions
a) Full Screening arm
Door frames will be made from 50 × 50 mm softwood.
The doors themselves will be constructed from 15 × 30
mm softwood, strengthened at the corners. Sheets of
white PVC-coated fibreglass netting (Vestergaard Frand-
sen group, Denmark) will be stretched and stapled over
the doors (Fig 2a). All doors will open inwards and will be
hung on the inside of any existing doors, unless prevented
from doing so by an immovable obstruction. Handles and
push bars will be fitted on both sides of the door and a
catch fixed on the inside to hold the door tight in the
frame when shut. Elastic cord will be attached to the out-
side of the door to pull the door closed when not in use.
Windows will be made in a similar fashion to the doors.
If the occupants do not need to open the window the net-
ting will be stapled straight onto the 50 × 50 mm frame. If
there is already a window in place then the screened win-
dow will be installed to the inside of the existing window,
and a sliding plywood panel fitted to enable access to the
outer window (Fig 2b). Eaves will be closed with a mix-
ture of sand, rubble and cement (Fig 2c).
b) Netting ceiling arm
Sheets of 2.4 m wide white PVC-coated fibreglass netting
(Vestergaard Frandsen group, Denmark) will be cut to fit
the room (leaving at least 50 cm overhang on all sides),
Installation of full screening intervention: a) screened door, b) screened window, c) closed eavesFigure 2
Installation of full screening intervention: a) screened door, b) screened window, c) closed eaves.
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over-lapped and stitched together with ribbon by a local
tailor. The netting will be centered over a plywood ceiling
rose which is tied by wire to a ceiling beam in the centre
of the room (Fig 3a,b). The overhang of the netting will be
tucked behind 10 × 40 mm softwood battens which will
then be screwed securely to the top of the walls (Fig 3c).
c) Control arm
Control houses receive no screening of any type and the
eaves remain open.
Mosquito collection
Each study house will be sampled biweekly during the
rainy season. A CDC miniature light trap (Model 512,
John W. Hock Co., Gainesville, FL) will be positioned 1 m
above the ground within 1–2 m of the foot end of a bed
protected with a new untreated bednet provided on that
night only. If the trapping room contains multiple beds,
then the other room occupants will be encouraged to use
their existing bednets. If they have none, additional new
bednets will be provided for that night. Light traps will be
operated from 19:00 to 07:00 h the following morning.
Mosquitoes will be killed by freezing at -25°C for 2 hours
and identified using morphological criteria. 1% of the An.
gambiae s.l. complex caught in the traps will be identified
to species by PCR analysis
Clinical data collection and patient treatment
All children older than 6 months and under the age of 10
years living in eligible houses in the study blocks will be
will be issued with an identity (ID) card, which they will
present for their correct identification in November at the
time of finger-pricking. Axillary temperature will be meas-
ured on arrival at the clinical station. A rapid dipstick test
(ICT malaria P.f Cassette Test, ICT Diagnostics, South
Africa) will be done for any child presenting with temper-
ature ≥ 37.5°C and/or history of fever in the last 48 h. A
blood sample will be taken from all children to measure
haemoglobin using a portable β-haemoglobin photome-
ter (Hemocue®, Ängelholm, Sweden).
In addition, using blood from the same finger-prick, the
nurse will make a thin and thick film for confirmation
and quantification of malaria parasites. Slides will be
numbered with the date of finger-pricking and the sub-
ject's randomly generated ID number, and transported to
MRC Laboratories Field Station, at Farafenni. Thick blood
films will be stained with Giemsa and examined under
1000-fold magnification. Parasite counts will be counted
per high power field and 50 fields counted before a slide
is declared negative. Parasite density per μL was calculated
assuming a blood volume per HPF of 0.002 μL. Thin films
will be stained in the field with Field's stain of water-based
Romanovsky. Plasmodium species will be identified from
thin films.
Children with Hb < 8 g/dL will be classified as anaemic
and given iron supplementation. Chloroquine and Fan-
sidar will be given to any child ICT-positive, and also to
children who were ICT-negative or not tested but were
subsequently blood-slide positive. The parents of any
child treated for malaria will be asked to bring their child
to the nearest Maternal and Child Health clinic if the child
is sick and does not recover within 48 h. Children with Hb
<5 g/dL will be taken to the Farafenni hospital and fol-
lowed up for two weeks after fingerpricking.
Clinical data will be recorded initially on the appropriate
forms, double entered into a computer by two separate
data entry clerks using Microsoft Access 2000, verified and
errors amended where appropriate. The original clinical
data will be kept in a locked cabinet and the key kept by
the local investigator. The digitized dataset will be kept in
a server, password protected and only accessed by the data
manager and PI at the MRC Laboratories in Farafenni, and
the data manager at the central MRC site in Fajara. Data
will be stored for at least 10 years.
Installation of netting ceiling intervention: a) assessing rose height, b) installing ceiling and rose, c) installing battensFigure 3
Installation of netting ceiling intervention: a) assessing rose height, b) installing ceiling and rose, c) installing battens.
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Sample Size Rationale
a) Entomological
It is considered that a reduction of at least 50% in mos-
quito catch is needed if the intervention is to be consid-
ered of value as a practical public health intervention. In
pilot studies of the ceiling intervention in experimental
huts[13], the reduction observed was 79% (95% CI 40–
94%). A 50% reduction was considered achievable in an
operational setting. Based on preliminary data a geomet-
ric mean catch of 15 female Anopheles gambiae s.l./trap/
night was anticipated in the control group, and a catch of
7.5 or less in intervention groups. It was considered that
interventions which differ in terms of mean catch by 2.5
mosquitoes/trap/night or less would be considered
equally effective. The trial was therefore planned to have
90% power to detect a 50% reduction in mosquitoes
between the control group and either intervention group
(i.e. from 15 to 7.5 mosquitoes/trap/night).
In addition we want to be able to rule out the possibility
of important differences between the two interventions.
Providing both interventions reduce mosquito biting by
more than half we think the choice of intervention will be
largely based around whether users like the screening and
the cost of the intervention. However, assuming both
interventions are liked equally well and they are of a sim-
ilar cost, we consider that a difference in protection
smaller than 50% in one arm and 67% in another would
not be of interest to health providers since the difference
would need to be greater in order to make an appreciable
change to the clinical pattern of malaria in a setting. In
Farafenni town we anticipated that, on average, people
would receive around one infective bite each year. Studies
in Tanzania have shown that a difference of 0.5 (50%
reduction) and 0.33 (67% reduction) would, for example,
have little impact on malaria prevalence (Bdker et al.,
unpublished data).
We have based our sample size calculations on discrimi-
nating between a mean of 7.5 (50% reduction) and 5.0
(67% reduction) mosquitoes/trap/night in the two inter-
vention groups. Assuming a SD of log(e) catch of 1.2, 181
houses per intervention group would be needed for a 2-
group 1-sided t-test to have 90% power to reject the null
hypothesis that the difference between the group means is
2.5 or more, with an alpha-level of 0.025 and assuming
the expected difference between the means is zero.
Thus in a three arm trial we required 200 houses rand-
omized in each intervention group and 100 in the control
arm, allowing for 10% of houses to be excluded from the
primary analysis due to withdrawal or non-adherence to
protocol.
b) Clinical
Our aim was to have 90% power to detect a difference in
mean haemoglobin of 0.5 g/dl between the two interven-
tion arms and the control arm in November, using a sig-
nificance level of 2.5% for each of the two comparisons of
intervention with control. In a recent trial in The Gambia
the SD was 1.7 g/dl. A difference of 0.5 g/dl is 0.3SD. The
interclass correlation (ICC) for haemoglobin in another
trial in Senegal varied from 0.04 to 0.08. Assuming a sim-
ilar ICC in the present trial the number of children
required to detect (with 90% power) a difference of 0.5 g/
dl is 166 in the control arm and 332 in each intervention
arm.
Analysis
a) Trial profile
All children in the study will be described in a flow chart
and/or the text to indicate, for each arm of the trial, the
number of children recruited, the number lost to follow
up and reasons for loss to follow up, and the number sam-
pled in November.
The trial profile will also show the number of houses con-
sidered for enrolment, the number excluded from the
study with reasons for exclusion, the number randomized
in each group, and the number withdrawn with reasons
for withdrawal.
b) Intention to treat (ITT) and according to protocol (ATP) analysis 
sets
The analysis of primary and secondary endpoints will be
considered two ways. Firstly we will adopt an 'intention to
treat' approach where the analysis is carried out using all
households that are randomized and for which there are
some outcome data. At enrolment of the house, a list of
children who normally sleep in the house will be made
and updated at the beginning of the rainy season to
include newborns and record any changes in occupancy.
At blood sampling in November, any children absent will
be listed with the reason they were missing. The ITT study
population for the anaemia endpoints is all children
included in the updated list. Analysis will be limited to
those who were sampled for Hb and parasitology in
November.
Secondly, we will adopt an 'according to protocol'
approach where the analysis is carried out using all houses
and study subjects in the control group, but excluding all
houses from either intervention group (and study chil-
dren that slept there) that have screening scored as 'badly
damaged' in a durability study conducted 6 months post
screening installation. The definition of 'badly damaged'
screens will be determined separately for homes in the
two treatment arms. In full screened houses damage will
equate to 5 or more holes in the screening and/or doors
Trials 2008, 9:33 http://www.trialsjournal.com/content/9/1/33
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not closing tightly. In screened ceiling houses damage will
equate to 5 or more holes in the screening and/or where
the netting has come away from the battens that secure the
screening to the walls.
ITT and ATP analyses will include stratification by year, by
rural/urban, and by block, which were stratification fac-
tors in the randomization. There will be no adjustment for
the number of children in each trial arm even though this
was a stratification factor in the randomization. We strat-
ified to ensure similar numbers in each trial arm for Hb
sampling, but the number of children in the house is not
expected to relate to any of the clinical outcome measures.
c) Data exclusions
Data exclusions will be tabulated for each trial arm. The
following data sets will be excluded from the analysis: (1)
light trap collections on nights when the light trap was not
working, (2) houses destroyed or vacated by residents, (3)
houses for which the occupier withdrew consent, (4)
evaporimeter readings greater than 30 mm.
d) Primary analysis of variables
Entomological data
Comparisons of mean number of mosquitoes/house
between intervention groups and the control group will
be made using ANOVA on the log mean catch for each
house. The mean will be calculated firstly as the Williams
mean (geometric mean after adding 1 to all values), and
in a secondary analysis, as the arithmetic mean. To allow
for the 2 comparisons being made (between the control
arm and each of the two interventions), P-values less than
0.025 will be considered significant and 97.5% confi-
dence intervals will be calculated. For the comparison
between the two intervention groups, we will estimate the
95% confidence interval for the ratio of the mean catch
per house. If the upper limit of this interval corresponds
to a difference in catch of 2.5 or less, the ceiling interven-
tion will be considered as effective as full screening.
Estimates of entomological inoculation rate (EIR) will be
generated by multiplying the mean number of mosqui-
toes/adult/house/night by the sporozoite rate (adjusted
for area and year) and multiplying this by the number of
nights during each year. The sporozoite rate, with a 95%
confidence interval, will be estimated for each arm of the
trial based on the number of positive and negative pools
and the number of individuals per pool, and a confidence
interval for the difference between trial arms will be esti-
mated for each pairwise comparison.
Clinical data
For each house, the mean Hb will be calculated and these
means compared between each intervention group and
the control group using ANOVA.
e) Secondary analysis
Entomological data
The secondary analysis will impute missing mosquito
catch data for nights when individual houses could not be
sampled. The analysis will be done adjusting for the same
variables as the primary analysis but including the follow-
ing covariates that have been shown to be associated with
mosquito catch size[14]: (1) presence of horse(s) tethered
near the house at night, (2) churai burnt in the trapping
room at night, (3) number of people sleeping in the trap-
ping room at night, (4) wall material (mud brick or con-
crete).
Night-to-night variation in covariates 1, 2 and 3 can be
accounted for as these will be recorded on every visit to
each house. Covariate 4 will obviously remain constant
throughout the trapping period for each house. We will
also include the presence of one or more ITNs in the
house, and socioeconomic status, in the list of covariates.
Socioeconomic status will be determined by principal
component analysis (PCA) from a list of household
assets.
Generalised estimating equations (GEE) will be used to
estimate treatment effect, adjusting for covariates. Differ-
ences in house entry by malaria mosquitoes experienced
in the three groups will be analysed based on count data,
using a generalised estimating equation to account for the
correlation between the longitudinal observations in the
same house comparing the number of mosquitoes caught
indoors in each house in each intervention group with the
control group.
Clinical data
The secondary analysis will be done adjusting for the
same variables as the primary analysis but including all
the covariates listed in the entomological analysis, with
three changes: (1) whether the study subject reports sleep-
ing under an ITN (rather than whether someone in the
trapping room uses an ITN as in the entomological analy-
sis), (2) whether the net was in good condition or not. A
net in good condition is one which is long enough to be
tucked under the mattress, is not torn or otherwise dam-
aged, and had no more than 5 small holes (finger-width,
approximate diameter ≤ 2 cm [15], (3) child's age. Inter-
actions with age will be investigated using age groups:
under 2 years old, 2–5 years, and 5–10 years old.
For the clinical variables (haemoglobin, anaemia, severe
anaemia, parasitaemia, high density parasitaemia and
parasite density in infected children), generalized estimat-
ing equations (GEE) will be used to estimate the odds
ratios between each intervention group and the control
group.
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Comparisons of clinical variables (haemoglobin, anae-
mia, severe anaemia, parasitaemia, high density parasitae-
mia and parasite density in infected children) between
intervention groups will be reported as the difference in
risk or the difference between means, with 95% confi-
dence intervals.
Ethical Approval
Ethical approval for this study was given by the Gambian
Government and Medical Research Council Laboratories
Joint Ethical Committee and the Ethics Advisory Commit-
tee of Durham University.
Discussion
This is a proof-of-concept trial to determine whether
screening can reduce malaria transmission. It is designed
to measure whether either full screening or screened ceil-
ings can reduce the exposure to An. gambiae s.l., the prin-
cipal vectors of malaria in Africa, and whether the
interventions can reduce anaemia in children.
Anaemia is a clinically relevant measure of malaria in chil-
dren. Typically in areas of intense seasonal transmission
like The Gambia it is measured in the same children at the
beginning and end of the rainy season [16-19]. However,
we choose not to measure anaemia at the start of the rainy
season because anaemic children would have to be
treated, interfering with the natural history of anaemia in
this community. Whilst we cannot be completely confi-
dent that the proportion of anaemic children will be the
same in each arm of the trial, randomization should result
in comparable groups. The only other foreseeable prob-
lem is the difficulty of locating the study participants. The
local population is highly mobile, particularly the fami-
lies of the herdsmen of the Fula ethnic group. Addition-
ally the children of all ethnic groups are often sent away
for schooling or weaning; this obviously presents difficul-
ties in associating child health with one particular house.
As far as possible, the interventions themselves will be
made using locally available materials. Although we will
be using high quality netting for screening, locally availa-
ble netting, although of inferior quality, is available in
Farafenni town. All timber, screws, nails and elastic cords
will be purchased locally and the interventions installed
by local carpenters. We aim is to achieve a standard
screening design within each intervention arm. However,
wall height poses a problem for installing ceilings. In
houses with high walls the netting will be stretched hori-
zontally across the room as this is the easiest installation
technique. In houses with low walls the ceiling must be
pulled up from the central rose into the roof space to
allow enough room at head height. In the full screening
intervention arm, installing door frames into houses with
narrow entrances further restricts access. The best way to
obviate this will be to widen the entrance, if the partici-
pants agree to this. Because of the large number of inter-
vention houses and the necessity to repeatedly sample for
mosquitoes during the rainy season it was felt prudent to
carry out the study over 2 successive rainy seasons so as
not to overburden the study team.
There are no apparent risks to the safety of individuals in
this trial, although finger-pricking is mildly uncomforta-
ble and the rooms may be stuffier when screened. How-
ever, there are a number of benefits for participants in this
trial. Prompt treatment for children with malaria and
anaemia will be provided for children at the end of each
rainy season. New untreated bednets will be provided
when mosquito sampling and ITNs given to all partici-
pants at the end of the trial. We anticipate that the inter-
ventions will be protective and that the 'no intervention'
control group will benefit by being given netting ceilings
or full screening at the end of the study period.
The findings from this study will enable us to evaluate a
range of different methods for screening homes against
mosquitoes. By focusing on an assessment of reducing
mosquito transmission in this study it will be possible to
better plan a second trial in order to assess the impact of
screening on the incidence of malaria morbidity in chil-
dren. Lessons learned from the trial will benefit the study
community, the Gambian Medical and Health Depart-
ment and other African Departments of Health. Although
house screening needs to be tailored to local house
designs, the general principles involved in this program
should help inform malaria control in many other African
countries and other parts of the tropics. The results of this
program will therefore be of interest to malaria control
programs, local administrations, industries with large
labour forces and non-Governmental Organisations
throughout sub-Saharan Africa. Moreover, there is grow-
ing international awareness amongst the research and
development communities that EM needs to be re-evalu-
ated in Africa today and projects such as this will help
guide the development of sustainable methods for pro-
tecting the poor and vulnerable from malaria.
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